Biomarin Pharmaceutical shares owned by Simplex Trading
Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Simplex Trading
from 13F filings
Historical chart of Simplex Trading investment in Biomarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharmaceutical held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Biomarin Pharmaceutical by Simplex Trading
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $8.7M | 124k | 70.28 |
2024-06-30 | $7.8M | 95k | 82.33 |
2024-03-31 | $6.2M | 71k | 87.33 |
2023-12-31 | $7.4M | 77k | 96.42 |
2023-09-30 | $3.6M | 41k | 88.47 |
2023-06-30 | $6.0M | 69k | 86.68 |
2023-03-31 | $4.8M | 49k | 97.24 |
2022-12-31 | $7.8M | 76k | 103.48 |
2022-09-30 | $5.5M | 65k | 84.77 |
2022-06-30 | $4.6M | 56k | 82.86 |
2022-03-31 | $1.6M | 20k | 77.06 |
2021-12-31 | $7.9M | 95k | 83.90 |
2021-09-30 | $7.9M | 95k | 83.90 |
2021-06-30 | $7.9M | 95k | 83.44 |
2021-03-31 | $6.2k | 827 | 7.55 |
2020-12-31 | $5.6k | 642 | 8.77 |
2020-09-30 | $6.1k | 806 | 7.61 |
2020-06-30 | $9.0k | 731 | 12.33 |
2020-03-31 | $5.9k | 697 | 8.45 |
2019-12-31 | $4.0k | 469 | 8.45 |
2019-09-30 | $1.1k | 161 | 6.74 |
2019-06-30 | $2.4k | 275 | 8.56 |
2019-03-31 | $3.8k | 429 | 8.88 |
2018-12-31 | $1.6k | 191 | 8.51 |
2018-09-30 | $2.8k | 289 | 9.70 |
2018-06-30 | $2.7k | 289 | 9.42 |
2018-03-31 | $50k | 99 | 505.05 |
2017-12-31 | $79k | 443 | 178.33 |
2017-09-30 | $32k | 202 | 158.42 |
2017-06-30 | $92k | 240 | 383.33 |
2017-03-31 | $39k | 167 | 233.53 |
2016-12-31 | $225k | 404 | 556.93 |
2016-09-30 | $106k | 340 | 311.76 |
2016-06-30 | $298k | 260 | 1146.15 |
2016-03-31 | $170k | 121 | 1404.96 |
2015-12-31 | $49k | 123 | 398.37 |
2015-09-30 | $326k | 134 | 2432.84 |
2015-06-30 | $58k | 133 | 436.09 |
2015-03-31 | $27k | 88 | 306.82 |
2014-12-31 | $2.0k | 48 | 41.67 |
Top funds holding Biomarin Pharmaceutical
View all funds holding Biomarin Pharmaceutical